Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

BACKGROUND/AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer disease. METHODS: Between 2002 and 2014, 110 patients in 14 medical centers received levofloxacin-based third-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Gut Liver
Autori principali: Lim, Joo Hyun, Kim, Sang Gyun, Song, Ji Hyun, Hwang, Jae Jin, Lee, Dong Ho, Han, Jae Pil, Hong, Su Jin, Kim, Ji Hyun, Jeon, Seong Woo, Kim, Gwang Ha, Shim, Ki-Nam, Shin, Woon Geon, Kim, Tae Ho, Kim, Sun Moon, Chung, Il-Kwon, Kim, Hyun-Soo, Kim, Heung Up, Lee, Joongyub, Kim, Jae Gyu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Editorial Office of Gut and Liver 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347646/
https://ncbi.nlm.nih.gov/pubmed/27609487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16099
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi